← Back to contracts

DoW Vision, Clinical Trial Award

US · MD Dept › of the Army -- U › S › Army Medical Research Acquisition Activity (USAMRAA) grant open #HT942526VRPCTA
Response due Nov 12, 2026 · 00:00 UTC

Summary

This is a federal grant/funding opportunity posted on Grants.gov by the U.S. Army Medical Research Acquisition Activity (USAMRAA) under the Department of the Army. The opportunity, numbered HT942526VRPCTA, is a Clinical Trial Award under the DoW (Diseases of the Warfighter) Vision program. It is currently posted as a synopsis, meaning full solicitation details may be forthcoming. The award is intended to support clinical trial research, likely related to vision-related conditions affecting military personnel or veterans.

How they evaluate

Submission: Grants.gov federal grants portal

Risks & flags

  • Opportunity is currently only a synopsis — full solicitation details, scope, and eligibility requirements are not yet available, limiting early preparation time for applicants.
  • Opportunity number format (HT942526VRPCTA) is highly specific and may correspond to a pre-identified program structure, which could limit competitive field.

Market context

inferred from NAICS
Professional, Scientific & Technical Services
NAICS 541711
US market size
$2.0T
Typical award
$25K – $50M
Typical buyers
All federal civilianDoDStates
Commonly required
8(a)WOSBSDVOSBPE/PMP

Sector-level estimate — full code lookup not yet in catalog.

DoW Vision, Clinical Trial Award
Due Nov 12
Onboard